{"downloaded": true, "htmlmade": false, "full": {"id": "30584165", "source": "MED", "pmid": "30584165", "pmcid": "PMC6311368", "fullTextIdList": {"fullTextId": "PMC6311368"}, "doi": "10.3233/jpd-181487", "title": "Updating Our Definitions of Parkinson's Disease for a Molecular Age.", "authorString": "Chen-Plotkin AS, Zetterberg H.", "authorList": {"author": [{"fullName": "Chen-Plotkin AS", "firstName": "Alice S", "lastName": "Chen-Plotkin", "initials": "AS", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA."}}}, {"fullName": "Zetterberg H", "firstName": "Henrik", "lastName": "Zetterberg", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, M\u00f6lndal, Sweden."}, {"affiliation": "Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M\u00f6lndal, Sweden."}, {"affiliation": "Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK."}, {"affiliation": "UK Dementia Research Institute at UCL, London, UK."}]}}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "s1", "volume": "8", "journalIssueId": "2763876", "dateOfPublication": "2018", "monthOfPublication": "0", "yearOfPublication": "2018", "printPublicationDate": "2018-01-01", "journal": {"title": "Journal of Parkinson's disease", "ISOAbbreviation": "J Parkinsons Dis", "medlineAbbreviation": "J Parkinsons Dis", "NLMid": "101567362", "ISSN": "1877-7171", "ESSN": "1877-718X"}}, "pubYear": "2018", "pageInfo": "S53-S57", "abstractText": "Clinical definitions of Parkinson's disease (PD) are over 200 years old, while neuropathological definitions- which are still the basis of how we define the disease now- are over 100 years old. We argue that for both clinical care and therapeutic development, these definitions need updating for the molecular age in which we live. We highlight specific instances in which genetic or biochemical biomarkers are increasingly used for clinical trial enrollment in the neurodegenerative diseases, suggesting that molecular definition(s) of PD are already emerging. We review candidate biomarkers for PD-related pathologies and highlight the need for further validation.", "affiliation": "Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.", "publicationStatus": "ppublish", "language": "eng", "pubModel": "Print", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "review-article", "Review", "Journal Article", "Research Support, N.I.H., Extramural"]}, "grantsList": {"grant": {"grantId": "U01 NS097056", "agency": "NINDS NIH HHS", "acronym": "NS", "orderIn": "0"}}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Brain", "meshQualifierList": {"meshQualifier": [{"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Humans"}, {"majorTopic_YN": "N", "descriptorName": "Parkinson Disease", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DI", "qualifierName": "diagnosis", "majorTopic_YN": "Y"}, {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}, {"abbreviation": "PA", "qualifierName": "pathology", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Disease Progression"}, {"majorTopic_YN": "N", "descriptorName": "alpha-Synuclein", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Biomarkers", "meshQualifierList": {"meshQualifier": {"abbreviation": "ME", "qualifierName": "metabolism", "majorTopic_YN": "N"}}}]}, "keywordList": {"keyword": ["Biomarkers", "alpha-Synuclein", "Parkinson\u2019s Disease", "Genetic Subtypes"]}, "chemicalList": {"chemical": [{"name": "alpha-Synuclein", "registryNumber": "0"}, {"name": "Biomarkers", "registryNumber": "0"}]}, "subsetList": {"subset": {"code": "IM", "name": "Index Medicus"}}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3233/JPD-181487"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6311368"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6311368?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by-nc", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-10-17", "dateOfCreation": "2018-12-26", "firstIndexDate": "2019-01-01", "fullTextReceivedDate": "2020-07-10", "dateOfRevision": "2020-03-09", "firstPublicationDate": "2018-01-01"}, "htmllinks": "https://europepmc.org/articles/PMC6311368", "abstract": "Clinical definitions of Parkinson's disease (PD) are over 200 years old, while neuropathological definitions- which are still the basis of how we define the disease now- are over 100 years old. We argue that for both clinical care and therapeutic development, these definitions need updating for the molecular age in which we live. We highlight specific instances in which genetic or biochemical biomarkers are increasingly used for clinical trial enrollment in the neurodegenerative diseases, suggesting that molecular definition(s) of PD are already emerging. We review candidate biomarkers for PD-related pathologies and highlight the need for further validation.", "Keywords": ["Biomarkers", "alpha-Synuclein", "Parkinson\u2019s Disease", "Genetic Subtypes"], "pdflinks": "https://europepmc.org/articles/PMC6311368?pdf=render", "journaltitle": "Journal of Parkinson's disease", "authorinfo": ["Chen-Plotkin AS", "Zetterberg H"], "title": "Updating Our Definitions of Parkinson's Disease for a Molecular Age."}